CD30 Expression on Allergen- and Non-Allergen-Specific T Cell Lines and its Role in Cytokine Production

Archivum Immunologiae et Therapiae Experimentalis

Volumn 51, Issue 5, 2003, Pages 335-343

  Tarkowski, Maciej ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

CD30; T cells; Th1; Th2

Indexed keywords

ALLERGEN; ANTIBODY; CD28 ANTIBODY; CD30 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; RECEPTOR; TUBERCULIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; ATOPY; CHEMICAL REACTION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; MALE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ADULT; ALLERGENS; ANTIGENS, CD30; CELL LINE; CYTOKINES; FEMALE; HUMANS; MALE; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0242656212     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ALZONA M., JACK H. M., FISHER R. I. and ELLIS T. M. (1994): CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol., 153, 2861-2867.
2. + T cells. J. Immunol., 154, 9-16.
3. BAMFORD K. B., FAN X., CROWE S. E., LEARY J. F., GOURLEY W. K., LUTHRA G. K., BROOKS E. G., GRAHAM D. Y., REYES V. E. and ERNST P. B. (1998): Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology, 114, 482-492.
4. CHILOSI M., FACCHETTI F., NOTARANGELO L. D., ROMAGNANI S., DEL PRETE G., ALMERIGOGNA F., DE CARLI M. and PIZZOLO G. (1996): CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Eur. J. Immunol., 26, 329-334.
5. D'ELIOS M. M., ROMAGNANI P., SCALETTI C., ANNUNZIATO F., MANGHETTI M., MAVILIA C., PARRONCHI P., PUPILLI C., PIZZOLO G., MAGGI E., DEL PRETE G. F. and ROMAGNANI S. (1997): In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J. Leukoc. Biol., 61, 539-544.
6. + T cells producing Th2-type cytokines. FASEB J., 9, 81-86.
7. DURKOP H., LATZA U., HUMMEL M., EITELBACH F., SEED B. and STEIN H. (1992): Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell, 68, 421-427.
8. + T cells. J. Immunol., 151, 2380-2389.
9. + T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. J. Immunol., 164, 4399-4407.
10. GILFILLAN M. C., NOEL P. J., PODACK E. R., REINER S. L. and THOMPSON C. B. (1998): Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines. J. Immunol., 160, 2180-2187.
11. GRUSS H. J., ULRICH D., DOWER S. K., HERRMANN F. and BRACH M. A. (1996): Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-Kβ transcription factor. Blood, 87, 2443-2449.
12. HARROP J. A., REDDY M., DEDE K., BRIGHAM-BURKE M., LYN S., TAN K. B., SILVERMAN C., EICHMAN C., DIPRINZIO R., SPAMPANATO J., PORTER T., HOLMES S., YOUNG P. R. and TRUNEH A. (1998): Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J. Immunol., 161, 1786-1794.
13. + cutaneous T-cell lymphoma. Blood, 101, 1487-1493.
14. LEONARD C., TORMEY V., BURKE C. and POULTER L. W. (1997): Allergen-induced cytokine production in atopic disease and its relationship to disease severity. Am. J. Respir. Cell. Mol. Biol., 17, 368-375.
15. LEONARD C., TORMEY V., FAUL J., BURKE C. M. and POULTER L. W. (1997): Allergen-induced CD30 expression on T cells of atopic asthmatics. Clin. Exp. Allergy, 27, 780-786.
16. MAVALIA C., SCALETTI C., ROMAGNANI P., CAROSSINO A. M., PIGNONE A., EMMI L., PUPILLI C., PIZZOLO G., MAGGI E. and ROMAGNANI S. (1997): Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am. J. Pathol., 151, 1751-1758.
17. + cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions. Int. Immunol., 9, 713-720.
18. PACHECO K. A. TARKOWSKI M., KLEMM J. and ROSENWASSER L. J. (1998): CD49d expression and function on allergen-stimulated T cells from blood and airway. Am. J. Respir. Cell. Mol. Biol., 18, 286-293.
19. ROSSI F. M., DEGAN M., MAZZOCUT-ZECCHIN L., DI FRANCIA R., ALDINUCCI D., PINTO A. and GATTEI V. (2001): CD30L up-regulates CD30 and IL-4 expression by T cells. FEBS Lett., 508, 418-422.
20. +Th2-type γδ T cells in bronchial asthma. Mol. Med., 1, 821-826.
21. STEIN H., MASON D. Y., GERDES J., O'CONNOR N., WAINSCOAT J., PALLESEN G., GATTER K., FALINI B., DELSOL G., LEMKE H., SCHWARTING R. and LENNERT K. (1985): The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood, 66, 848-858.
22. TARKOWSKI M. (1999): Expression and function of CD30 on T lymphocytes. Arch. Immunol. Ther. Exp., 47, 217-221.
23. TARKOWSKI M., CHRUL S. and BODALSKI J. (1999): The Effect of IL-18 on CD30 expression and cytokine production by allergic and non-allergic T cell lines. J. Allergy Clin. Immunol., 103, S108.
24. TARKOWSKI M., CHRUL S. and BODALSKI J. (2002): The effect of IL-18 on IL-12-induced CD30 expression and IL-4 and IFN-γ production by allergen and PPD specific T cells. Clin. Exp. Immunol., 127, 78-84.
25. + cells. Int. Arch. Allergy Immunol., 121, 25-33.
26. VINANTE F., RIGO A., SCUPOLI M. T. and PIZZOLO G. (2002): CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540. Blood, 99, 52-60.